Management strategies for three patients with gynecological malignancies during the outbreak of COVID-19
Objective: To explore the management strategies for patients with gynecological malignant tumors during the outbreak and transmission of COVID-19. Methods: We retrospectively analyzed the clinical characteristics, treatment, and disease outcomes of three patients with gynecological malignancies associated with COVID-19 in Renmin Hospital of Wuhan University, and proposed management strategies for patients with gynecological tumors underriskof COVID-19. Results: Based on the national diagnosis and treatment protocol as well as research progress for COVID-19, three patients with COVID-19 were treated. Meanwhile, they were also appropriately adjusted the treatment plan in accordance with the clinical guidelines for gynecological tumors. Pneumonia was cured in 2 patients, and one patient died of COVID-19. Conclusions: Patients with gynecological malignant tumors are high-risk groups prone to COVID-19, and gynecological oncologists need to carry out education, prevention, control and treatment according to specific conditions. While, actively preventing and controlling COVID-19, the diagnosis and treatment of gynecological malignant tumors should be carried out in an orderly and safe manner.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:55 |
---|---|
Enthalten in: |
Zhonghua fu chan ke za zhi - 55(2020), 4 vom: 25. Apr., Seite 221-226 |
Sprache: |
Chinesisch |
---|
Beteiligte Personen: |
Zhang, J [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
Date Completed 13.05.2020 Date Revised 18.12.2020 published: Print Citation Status MEDLINE |
---|
doi: |
10.3760/cma.j.cn112141-20200302-00168 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM307620506 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM307620506 | ||
003 | DE-627 | ||
005 | 20231225125948.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||chi c | ||
024 | 7 | |a 10.3760/cma.j.cn112141-20200302-00168 |2 doi | |
028 | 5 | 2 | |a pubmed24n1025.xml |
035 | |a (DE-627)NLM307620506 | ||
035 | |a (NLM)32174096 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a chi | ||
100 | 1 | |a Zhang, J |e verfasserin |4 aut | |
245 | 1 | 0 | |a Management strategies for three patients with gynecological malignancies during the outbreak of COVID-19 |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 13.05.2020 | ||
500 | |a Date Revised 18.12.2020 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Objective: To explore the management strategies for patients with gynecological malignant tumors during the outbreak and transmission of COVID-19. Methods: We retrospectively analyzed the clinical characteristics, treatment, and disease outcomes of three patients with gynecological malignancies associated with COVID-19 in Renmin Hospital of Wuhan University, and proposed management strategies for patients with gynecological tumors underriskof COVID-19. Results: Based on the national diagnosis and treatment protocol as well as research progress for COVID-19, three patients with COVID-19 were treated. Meanwhile, they were also appropriately adjusted the treatment plan in accordance with the clinical guidelines for gynecological tumors. Pneumonia was cured in 2 patients, and one patient died of COVID-19. Conclusions: Patients with gynecological malignant tumors are high-risk groups prone to COVID-19, and gynecological oncologists need to carry out education, prevention, control and treatment according to specific conditions. While, actively preventing and controlling COVID-19, the diagnosis and treatment of gynecological malignant tumors should be carried out in an orderly and safe manner | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Coronavirus infections | |
650 | 4 | |a Cross infection | |
650 | 4 | |a Genital neoplasms, female | |
650 | 4 | |a Infection control | |
650 | 4 | |a Patient care management | |
700 | 1 | |a Peng, P |e verfasserin |4 aut | |
700 | 1 | |a Li, X |e verfasserin |4 aut | |
700 | 1 | |a Zha, Y F |e verfasserin |4 aut | |
700 | 1 | |a Xiang, Y |e verfasserin |4 aut | |
700 | 1 | |a Zhang, G N |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Y |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Zhonghua fu chan ke za zhi |d 1960 |g 55(2020), 4 vom: 25. Apr., Seite 221-226 |w (DE-627)NLM00096333X |x 0529-567X |7 nnns |
773 | 1 | 8 | |g volume:55 |g year:2020 |g number:4 |g day:25 |g month:04 |g pages:221-226 |
856 | 4 | 0 | |u http://dx.doi.org/10.3760/cma.j.cn112141-20200302-00168 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 55 |j 2020 |e 4 |b 25 |c 04 |h 221-226 |